Introduction
Chili peppers are commonly used as an ingredient in many cuisines and are eaten by many people around the world. Capsaicinoids, including capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homodihydrocapsaicin, and homocapsaicin, are the major active components of chili peppers, which not only add spice to the food but also possess potential anticancer (Surh, 2002; Zhang et al., 2003; Oh and Lim, 2009; Choi et al., 2010a; Ghosh and Basu, 2010; Thoennissen et al., 2010; Yang et al., 2010; Jin et al., 2014) , antiinflammatory (Lee et al., 2010) , antioxidant (Nascimento et al., 2014) , antiobesity (Reinbach et al., 2009; Saito and Yoneshiro, 2013) , and analgesic (Knotkova et al., 2008) activities. Capsaicin, the most abundant capsaicinoid found in chili peppers, has been shown to bind vanilloid receptors on the cell membranes of various cell types (Jordt and Julius, 2002) . Vanilloid receptors are a nonselective cation channel gated by noxious heat, vanilloids, and extracellular protons and are involved in the etiology of inflammatory pain, such as inflammatory bowel disease, bladder inflammation, and cancer pain (Messeguer et al., 2006) . The role of vanilloid receptors in the cytotoxicity of capsaicin is not fully understood, but is likely that different cell lines respond in unique manners to stimulation of this receptor by capsaicin/ligand binding (Reilly et al., 2003) . Although the anticancer activity of capsaicin has been extensively documented, there is evidence that some capsaicin metabolites may cause DNA damage, leading to carcinogenesis (Baez et al., 2010) . Lui et al. (2012) demonstrated that capsaicin at low concentrations upregulated the expression of tumor-associated NADH oxidase in the human colon carcinoma cell line HCT116, in association with enhanced cell proliferation and migration. Furthermore, epidemiological data showed that people who consume chili peppers in large amounts have a higher risk of gastric cancer (Lopez-Carillo et al., 1994) . Therefore, capsaicin has been considered a doubleedged sword with both carcinopreventive and carcinogenic properties. Nonetheless, capsaicin is not mentioned in the current list of natural chemopreventive agents (Mehta, 2014) . Moreover, its high concentration requirement is a potential limitation for the use of capsaicin in cancer therapy (Luo et al., 2011) . Accordingly, modification of capsaicin's chemical structure may overcome the drawbacks of this naturally available compound.
Recently, inhibition of histone deacetylase (HDAC) activity has been considered a promising mechanism for cancer therapy, especially for combination chemotherapy (Carew et al., 2008; Bots and Johnstone, 2009; Ma et al., 2009; Mark and Xu, 2009 ). In the last 15 years, a number of HDAC inhibitors from natural sources and from chemical libraries have been studied, particularly their anticancer activity or toxicity on various cancer cell lines (Mark and Xu, 2009) . However, there is a continuous need to develop new HDAC inhibitors with better pharmacological efficacy and novel modes of action in comparison to known HDAC inhibitors. Based on the structural similarity of capsaicin to the potent HDAC inhibitors trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), several capsaicin derivatives were synthesized (Kumboonma, 2010) in order to explore potential therapeutic drugs from capsaicin-based compounds. In this study, the HDAC inhibitory activity of a capsaicin derivative, hydroxycapsaicin (6-hydroxy-N-(4-hydroxy-3-methoxybenzyl)-8-methylnonenamide), was evaluated comparatively with a prototype capsaicin. The cytotoxic effects of hydroxycapsaicin on growth, apoptosis, and cellcycle progression of human colon cancer cell lines were investigated in order to validate its anticancer potency, which would lead to a future study on its possible use as an anticancer agent.
Materials and methods

Cell lines and reagents
HCT116 and HT29 cells (human colon cancer cells) were obtained from Dr Osamu Tetsu (University of California, San Francisco, USA) and Dr Pornticha Picha (National Cancer Institute, Thailand), respectively. Both cell lines possess capsaicin/vanilloid receptors on their cell membrane (Bromberg et al., 2013; de Jong et al., 2014) . Vero cells (African green monkey kidney cells) obtained from Dr Sahapat Barusrux (Khon Kaen University, Thailand) were chosen for this study as they lack a capsaicin receptor (Creppy et al., 2000) . Capsaicin was purchased from Sigma-Aldrich Corporation (USA). Hydroxycapsaicin was synthesized as previously described (Kumboonma, 2010) .
Cell culture
HCT116, HT29, and Vero cells were maintained in RPMI-1640 supplemented with 10% fetal bovine serum, 100 U/ mL penicillin, and 100 µg/mL streptomycin (Gibco-BRL) at 37 °C in a humidified incubator with an atmosphere of 95% air and 5% CO 2 .
Assessment of HDAC inhibition in vitro
Inhibition of HDAC activity in vitro was assessed using the Fluor-de-Lys HDAC activity assay kit (Biomol, Enzo Life Sciences International, Inc., USA). HeLa nuclear extract provided with the kit was used as a source of HDAC enzymes for in vitro study. The spectra Max Gemini XPS microplate spectrofluorometer (Molecular Devices, USA) was used to measure fluorescence signal with excitation at 360 nm and emission at 460 nm. A decrease in fluorescence signal indicated an inhibition of HDAC activity.
Assessment of HDAC inhibition in human cells
HeLa cells with high levels of HDAC expression were chosen as a cellular model for evaluation of HDAC inhibition in human cells. Cells (1 × 10 6 cells) were seeded into a 4.5-cm dish. After incubation for 24 h, cells were treated with hydroxycapsaicin (50-200 µg/mL) for 6 h. Cells treated with a pan HDAC inhibitor TSA (5 nM) and DMSO (0.37%) were used as positive and negative controls, respectively. Histone proteins were extracted from treated cells as previously described (Senawong et al., 2013) . Acetylated histone H4 in HeLa cells was determined by acid-urea-Triton (AUT) polyacrylamide gel electrophoresis.
AUT X-100 polyacrylamide gel electrophoresis
To evaluate HDAC inhibition in human cells, AUT gel electrophoresis was used to measure hyperacetylation of histone H4 as described previously (Senawong et al., 2013) . AUT gels were stained using the PageSilver Silver Staining Kit (Fermentas, Canada). The abundance of triacetylated histone H4 was quantified with Quantity One software (Bio-Rad, USA). 2.6. MTT assay Determination of antiproliferative activity or cytotoxicity of hydroxycapsaicin and capsaicin was performed using MTT assay as described previously (Senawong et al., 2013) with some modifications. In brief, HT29, HCT116, and Vero cells were treated with hydroxycapsaicin and capsaicin at varied concentrations (25, 50, 100, 200 , 400 µg/mL), and incubated for 24, 48, and 72 h. After replacing culture medium, the cells were treated with 10 µL of MTT for 2 h at 37 °C. The formazan dye was dissolved with DMSO and determined by measuring the absorbance at 550 nm, using the absorbance at 655 nm as a reference wavelength with a microplate reader (Bio-Rad Laboratories, USA). The production of formazan was proportional to the number of viable cells.
Analysis of apoptosis by flow cytometry
Apoptosis analysis was performed using Vybrant Apoptosis Assay Kit #2 (Molecular Probes, Invitrogen Corporation, USA) according to the manufacturer's instructions. HT29, HCT116, and Vero cells (1 × 10 6 cells) were seeded into a 4.5-cm dish and treated with various concentrations of hydroxycapsaicin or capsaicin (50, 100, 200 µg/mL) for 24 h. Cells were then harvested by trypsinization, washed with PBS, and resuspended in ice-cold annexin-binding buffer added to Alexa Fluor 488 annexin V and propidium iodide (PI) solutions. Cells were stained in the dark for 15 min at room temperature and analyzed by flow cytometry using a BD FACSCantoII Flow Cytometer (Becton Dickinson, USA).
Analysis of cell-cycle arrest by flow cytometry
Cell-cycle phase distribution was determined as previously described (Poolman and Brooks, 1998) . Briefly, HT29, HCT116, and Vero cells were seeded into a 5.5-cm dish (1 × 10 6 cells/dish), incubated for 24 h, and treated with hydroxycapsaicin and capsaicin (50, 100, and 200 µg/ mL) or vehicle (DMSO, 0.37%) for 24 h. Cells were then harvested by trypsinization and washed once with PBS. Cells were fixed in 1 mL of ice-cold 70% ethanol for 30 min at 4 °C and then centrifuged at 340 × g for 5 min. The pellet was resuspended in 0.5 mL of PBS and subsequently added to 10 µL of PI staining solution (50 µg/mL of PI in PBS) and 0.1 mg/mL of RNase. After incubation at 37 °C for 40 min, the stained cells were subjected to flow cytometric analysis using a BD FACSCantoII flow cytometer (Becton Dickinson, Canada).
Statistical analysis
All quantitative data are expressed as means ± standard deviation (SD) calculated from 3 replicate experiments. All the statistical analysis was carried out by SPSS 11.5 for Windows (SPSS Corporation, USA). The significant difference between 2 groups was assessed by one-way ANOVA with Duncan's post hoc test. A probability value of P < 0.05 was set for statistical difference.
Results
Hydroxycapsaicin exhibited greater HDAC inhibitory activity than the prototype capsaicin in vitro
Capsaicin shares some structural characteristics, including a benzene ring and a long hydrophobic carbon tail, with pan HDAC inhibitors TSA and SAHA. We first investigated the in vitro HDAC inhibitory activity of capsaicin using HeLa nuclear extract as a source of HDAC enzymes; however, capsaicin showed little effect on HDAC inhibition in vitro, with an IC 50 value of >4001 µg/mL (>13,000 µM) (Table  1) . Therefore, hydroxycapsaicin was synthesized by adding a hydroxyl group to a position near the end of a long hydrophobic carbon tail in order to mimic the chemical structure of SAHA and TSA (Kumboonma, 2010) . As expected, hydroxycapsaicin exhibited HDAC inhibitory activity in vitro with an IC 50 value of 23.29 µg/mL (72 µM) (Table 1) , indicating a greater HDAC inhibition potency than the prototype capsaicin. Nonetheless, HDAC inhibitory activity of hydroxycapsaicin was much less potent compared with that of the pan HDAC inhibitor, TSA (IC 50 = 0.049 µM).
HDAC inhibitory activity of hydroxycapsaicin in HeLa cells
Based on our findings from the in vitro study, we next investigated the HDAC inhibitory activity of hydroxycapsaicin in a cellular context. In general, HDAC inhibition causes accumulation of acetylated histone molecules. Therefore, hyperacetylation of histone H4 in HeLa cells was investigated upon treatment with hydroxycapsaicin. HeLa cells were chosen as a model system because they express many HDAC isozymes, including HDAC 1, 2, 3, 4, and 8 (Hassig et al., 1998; Hu et al., 2000; Fischle et al., 2002; Khan 
Effect of hydroxycapsaicin on apoptosis induction in human colon cancer cell lines
Capsaicin inhibited the growth of several cancer cells via induction of both apoptosis (Lin et al., 2013; Jin et al., 2014) and autophagy (Oh and Lim, 2009; Choi et al., 2010b) . However, cancer cell death via apoptosis induction is more preferable in cancer therapy due to the cytoprotective role of autophagy (Vazquez-Martin et al., 2009; Dalby et al., 2010) . To confirm that induction of apoptosis underlies the antiproliferative activity of hydroxycapsaicin, its capacity to induce apoptosis in colon cancer cell lines was examined. Colon cancer cell lines and Vero cells were treated comparatively with different concentrations (50, 100, 150 mg/ mL) of both hydroxycapsaicin and capsaicin for 24 h and then stained with Alexa Fluor 488-annexin V and PI, followed by 
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Late apoptosis Early apoptosis in Vero cells (Figure 2A ), indicating that hydroxycapsaicin was much less toxic than capsaicin in a cell line lacking capsaicin/vanilloid receptors (Creppy et al., 2000) . These results suggest that apoptosis induction by both capsaicin and hydroxycapsaicin in cancer cells may be influenced by a capsaicin/vanilloid receptor on the cell membrane. Although apoptosis induction of hydroxycapsaicin and capsaicin in HT29 cells was not significantly different ( Figure 2C ), apoptosis induction of hydroxycapsaicin in HCT116 cells was greater than that of capsaicin ( Figure 2B ).
Effect of hydroxycapsaicin on induction of cell-cycle arrest in human colon cancer cell lines
In addition to apoptosis induction, cell-cycle arrest may also underlie a growth inhibition effect of hydroxycapsaicin. The possible effect of hydroxycapsaicin on cell-cycle progression was investigated comparatively with capsaicin in both Vero cells and colon cancer cell lines. As shown in Figures 3A-3F , a significant dose-dependent alteration of cell numbers in different cell-cycle phases was observed. In both Vero cells and colon cancer cells, capsaicin treatments for 24 h caused substantial cell death/apoptosis with the dramatic increase of the sub-G0/G1 peak ( Figures 3A, 3C , and 3E), whereas hydroxycapsaicin induced lower levels of cell death at high concentrations ( Figures 3B, 3D , and 3F). In Vero cells, capsaicin treatments at 50 and 100 µg/ mL for 24 h induced an increase of cells in the S-phase of the cell-cycle ( Figure 3A) . Interestingly, hydroxycapsaicin treatment at the highest concentration (200 µg/mL) for 24 h induced both an elevation of cell death and cell-cycle arrest at the S and G2/M phases in Vero cells ( Figure  3B ). In both HCT116 and HT29 cells, hydroxycapsaicin treatment caused cell-cycle arrest at the S-phase of the cell cycle ( Figures 3D and 3F ). In contrast, capsaicin treatment caused no cell-cycle arrest ( Figures 3C and 3E ) in these colon cancer cells.
Discussion
HDAC inhibition by HDAC inhibitors shows promising effects for cancer therapy (Mark and Xu, 2009) . Although the link between HDAC inhibition and apoptosis induction is not fully understood, treatments with HDAC inhibitors usually cause a shift in the balance of pro-and antiapoptotic genes toward apoptosis (Carew et al., 2008) . The cellular response to HDAC inhibition is complicated and appears to involve both transcriptional and nontranscriptional events. The substrates for HDAC enzymes are not only the histone proteins but also more than 50 nonhistone proteins, such as transcription factors, DNA repair proteins, DNA-binding proteins, chaperone proteins, and signal-transduction molecules (Ocker, 2010) . Inhibition of HDAC enzymes promotes the acetylation of both histone and nonhistone proteins, resulting in downregulation of prosurvival proteins such as Bcl-2 and Bcl-1, which maintain integrity of mitochondria (Rikiishi, 2011) , and upregulation of proapoptotic proteins such as Bim, Bak, and Bax, which initiate intrinsic cell death pathways (Zhao et al., 2005; Zhang et al., 2006) . In addition, hyperacetylation has been shown to stabilize p53 and activate cell-cycle arrest in cancer cells (Xu, 2006) . However, the link between hydroxycapsaicin-induced hyperacetylation and induction of cell-cycle arrest and apoptosis in both HT29 and HCT116 cells (Figures 2 and  3) remains to be investigated. There are 11 family members of zinc-dependent HDACs (Martinez-Iglesias et al., 2008; Mark and Xu, 2009) , which commonly have a narrow pocket and zinc (Zn 2+ ) ion in the catalytic site. The general structural characteristics of TSA and SAHA that strongly inhibit zinc-dependent HDAC isozymes include a zincbinding moiety, an opposite capping group, and a straightchain alkyl linker connecting the zinc-binding moiety and the capping group (Finnin et al., 1999; Mark and Xu, 2009 ). Based on its structural similarity with SAHA and TSA, we hypothesized that hydroxycapsaicin may have a similar orientation and binding mode as SAHA or TSA in the active site of zinc-dependent HDACs. Here we demonstrated that hydroxycapsaicin could inhibit HDAC activity both in vitro and in human cells. However, hydroxycapsaicin exhibited little effect on HDAC inhibition in a cellular model (Figure 1 ) and its HDAC inhibitory activity did not correspond well with the in vitro results (Table 1) . The minimal HDAC inhibition by hydroxycapsaicin in HeLa cells may result from the existence of vanilloid receptor (TRPV1) on the plasma membrane of this cell line (Ahn et al., 2014) , preventing some hydroxycapsaicin molecules from entering the cells.
The HDAC inhibitory activity of hydroxycapsaicin makes it more attractive in combination chemotherapy because HDAC enzymes are different chemotherapeutic drug targets than those of highly effective chemotherapeutic drugs such as cisplatin, 5-fluorouracil, and doxorubicin. For example, combination therapies using HDAC inhibitors vorinostat and sodium butyrate with aurora kinase inhibitors and doxorubicin, respectively, enhance activity against cancer cells (Cheriyath et al., 2011; Kretzner et al., 2011) . Accordingly, further studies on specificity for specific HDAC family members and HDAC inhibition in more cancer cell lines of hydroxycapsaicin are of interest.
Hydroxycapsaicin was synthesized to provide a novel HDAC inhibitor and to overcome capsaicin's toxicity. Here we demonstrated that a novel HDAC inhibitor, hydroxycapsaicin, was about 2 times less toxic than the prototype capsaicin in both colon cancer cell lines and a cell line lacking capsaicin receptor (Table 2) . Our preliminary data revealed that hydroxycapsaicin inhibited cell proliferation through induction of apoptosis (Figure 2 ) and cell-cycle arrest (Figure 3) . Capsaicin was more toxic to Table 2 ), suggesting that capsaicin toxicity might be affected by the capsaicin receptor. Capsaicin has been shown to inhibit cell proliferation via inhibition of protein synthesis (Creppy et al., 2000) and endoplasmic reticulum stress-induced autophagy/apoptosis (Oh and Lim, 2009) . It is of interest to investigate whether hydroxycapsaicin may exert the same mechanisms as capsaicin to inhibit cell proliferation.
The aim of chemotherapy is to kill cancer cells by inducing apoptosis. In this study, we identified apoptotic cells by detecting the "eat-me" signal of apoptotic cells (Ravichandran, 2010) , an externalized phosphatidylserine, using a combined annexin V/PI dual staining assay. Here we demonstrated that the effect of hydroxycapsaicin on apoptosis induction was greater than that of capsaicin in HCT116 cells (p53 wild type), but not different in HT29 cells (p53 mutant) (Figure 2 ). This apparent finding suggests that the presence of p53 may facilitate apoptosis induction by hydroxycapsaicin. However, the involvement of p53 in apoptosis induction by hydroxycapsaicin in HCT116 cells remains to be clarified.
In addition to apoptosis induction, cell-cycle arrest is also a mechanism to suppress cancer cell growth. However, the induction of cell-cycle arrest by capsaicin appeared to be specific to cell type and to play a limited role in some cancer cells, including KB cells (Lin et al., 2013) . Consistently, in this study, cell-cycle arrest was not observed upon capsaicin treatment in either HCT116 or HT29 cells ( Figures 3C and 3E) , in which the suppression of their growth may be more correlated with induction of cell death/apoptosis. Interestingly, hydroxycapsaicin, with HDAC inhibitory activity and less toxicity, suppressed the growth of both colon cancer cell lines, at least in part, via induction of cell-cycle arrest at the S-phase. However, the molecular mechanisms underlying hydroxycapsaicininduced cell-cycle arrest at the S-phase in both colon cancer cell lines are unknown and further investigation is needed.
In conclusion, hydroxycapsaicin, a capsaicin-based HDAC inhibitor, exhibited HDAC inhibitory effects both in vitro and in cellular model. However, vanilloid receptors may limit the effect of its HDAC inhibitory activity in a cellular context. Exposure of both colon cancer cell lines (HCT 116 and HT29 cells) to hydroxycapsaicin reduced cell proliferation, induced apoptosis, and stimulated cell-cycle arrest at the S-phase. These findings suggest that hydroxycapsaicin possesses HDAC inhibitory and anticancer activities and may be a potential anticancer drug.
